Found: 507
Select item for more details and to access through your institution.
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1191217
- By:
- Publication type:
- Article
Cellular Basis of Adjuvant Role of n-3 Polyunsaturated Fatty Acids in Cancer Therapy: Molecular Insights and Therapeutic Potential against Human Melanoma.
- Published in:
- Applied Sciences (2076-3417), 2024, v. 14, n. 11, p. 4548, doi. 10.3390/app14114548
- By:
- Publication type:
- Article
Treatment Strategies in Advanced-Stage Hodgkin Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2059, doi. 10.3390/cancers16112059
- By:
- Publication type:
- Article
The capability of pure and modified boron carbide nanosheet as a nanocarrier for dacarbazine anticancer drug delivery: DFT study.
- Published in:
- Pramana: Journal of Physics, 2024, v. 98, n. 2, p. 1, doi. 10.1007/s12043-023-02701-2
- By:
- Publication type:
- Article
Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03371-9
- By:
- Publication type:
- Article
The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03431-x
- By:
- Publication type:
- Article
Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.
- Published in:
- Molecules, 2024, v. 29, n. 10, p. 2346, doi. 10.3390/molecules29102346
- By:
- Publication type:
- Article
Head and Neck Malignant Paragangliomas: Experience from a Single Institution.
- Published in:
- ENT: Ear, Nose & Throat Journal, 2024, v. 103, n. 5, p. 298, doi. 10.1177/01455613211052338
- By:
- Publication type:
- Article
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 3, p. 352, doi. 10.1111/pcmr.13156
- By:
- Publication type:
- Article
Performance of C<sub>60</sub> fullerene, pristine, and Si/Al-doped B<sub>12</sub>N<sub>12</sub> fullerenes as potential sensor for dacarbazine drug.
- Published in:
- Theoretical Chemistry Accounts: Theory, Computation, & Modeling, 2024, v. 143, n. 5, p. 1, doi. 10.1007/s00214-024-03109-w
- By:
- Publication type:
- Article
Complex assessment of in vitro anti-melanoma action of medicinal plant Cotinus coggygria Scop.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2024, v. 23, n. 5, p. 815, doi. 10.4314/tjpr.v23i5.3
- By:
- Publication type:
- Article
Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China.
- Published in:
- Infectious Agents & Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13027-024-00571-w
- By:
- Publication type:
- Article
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4533, doi. 10.3390/ijms25084533
- By:
- Publication type:
- Article
The Synthesis of 2′-Hydroxychalcones under Ball Mill Conditions and Their Biological Activities.
- Published in:
- Molecules, 2024, v. 29, n. 8, p. 1819, doi. 10.3390/molecules29081819
- By:
- Publication type:
- Article
Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation.
- Published in:
- Drug Development Research, 2024, v. 85, n. 2, p. 1, doi. 10.1002/ddr.22163
- By:
- Publication type:
- Article
Iron Oxide Nanoparticles: Selectively Targeting Melanoma Cells In Vitro by Inducing DNA Damage via H2AX Phosphorylation and Hindering Proliferation through ERK Dephosphorylation.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 4, p. 527, doi. 10.3390/pharmaceutics16040527
- By:
- Publication type:
- Article
The role of GAPDH in the selective toxicity of CNP in melanoma cells.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300718
- By:
- Publication type:
- Article
Ce6-modified Fe ions-doped carbon dots as multifunctional nanoplatform for ferroptosis and photodynamic synergistic therapy of melanoma.
- Published in:
- Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02346-2
- By:
- Publication type:
- Article
Persistent β-Hexachlorocyclohexane Exposure Impacts Cellular Metabolism with a Specific Signature in Normal Human Melanocytes.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 5, p. 374, doi. 10.3390/cells13050374
- By:
- Publication type:
- Article
Cytotoxicity of ZIF-8@APTES-MS on murine melanoma cells.
- Published in:
- Journal of Materials Science, 2024, v. 59, n. 9, p. 3959, doi. 10.1007/s10853-023-09214-8
- By:
- Publication type:
- Article
Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13709
- By:
- Publication type:
- Article
Ruthenium(II) complex with 2-mercaptothiazoline ligand induces selective cytotoxicity involving DNA damage and apoptosis in melanoma cells.
- Published in:
- Journal of Biological Inorganic Chemistry (JBIC), 2024, v. 29, n. 1, p. 159, doi. 10.1007/s00775-023-02036-8
- By:
- Publication type:
- Article
Exploring the Antimelanoma Potential of Betulinic Acid Esters and Their Liposomal Nanoformulations.
- Published in:
- Processes, 2024, v. 12, n. 2, p. 416, doi. 10.3390/pr12020416
- By:
- Publication type:
- Article
Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45158-6
- By:
- Publication type:
- Article
Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 267, doi. 10.3390/cancers16020267
- By:
- Publication type:
- Article
Association between glycemic traits and melanoma: a mendelian randomization analysis.
- Published in:
- Frontiers in Genetics, 2024, p. 1, doi. 10.3389/fgene.2023.1260367
- By:
- Publication type:
- Article
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6900
- By:
- Publication type:
- Article
Exploring Herbal Remedies For Skin Cancer: A Comprehensive Review.
- Published in:
- Journal of Advanced Zoology, 2024, v. 45, n. 1, p. 951
- By:
- Publication type:
- Article
Evaluation of the Antitumor Activity of Quaternary Ammonium Surfactants.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17237, doi. 10.3390/ijms242417237
- By:
- Publication type:
- Article
Nanofibers based on zein protein loaded with tungsten oxide for cancer therapy: fabrication, characterization and in vitro evaluation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-49190-2
- By:
- Publication type:
- Article
Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 50, p. 1, doi. 10.1002/ange.202314025
- By:
- Publication type:
- Article
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage.
- Published in:
- Pigment Cell & Melanoma Research, 2023, v. 36, n. 6, p. 512, doi. 10.1111/pcmr.13114
- By:
- Publication type:
- Article
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
- Published in:
- Thyroid, 2023, v. 33, n. 11, p. 1368, doi. 10.1089/thy.2023.0144
- By:
- Publication type:
- Article
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP).
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 5, p. 579, doi. 10.1007/s00428-023-03660-0
- By:
- Publication type:
- Article
FILM-FORMING COMPOSITIONS BASED ON POLYURETHANEUREAS WITH EXTENDED RELEASE OF DACARBAZINE.
- Published in:
- Polymer Journal / Polymernyi Zhurnal (18181724), 2023, v. 45, n. 4, p. 319, doi. 10.15407/polymerj.45.04.319
- By:
- Publication type:
- Article
Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13242, doi. 10.3390/ijms241713242
- By:
- Publication type:
- Article
Melanin-targeted [<sup>18</sup>F]-PFPN PET imaging for prognosticating patients with melanoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3062, doi. 10.1007/s00259-023-06258-5
- By:
- Publication type:
- Article
Multiple cancers escape from multiple MAPK pathway inhibitors and use DNA replication stress signaling to tolerate aberrant cell cycles.
- Published in:
- Science Signaling, 2023, v. 16, n. 796, p. 1, doi. 10.1126/scisignal.ade8744
- By:
- Publication type:
- Article
Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40312-y
- By:
- Publication type:
- Article
The Effect of Cell-Free DNA from Blood Serum of Mice with Metastatic Melanoma on Enhancement of Oncogenic Properties of Melanoma Cells.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 7, p. 995, doi. 10.1134/S0006297923070118
- By:
- Publication type:
- Article
Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 2054, doi. 10.3390/biomedicines11072054
- By:
- Publication type:
- Article
Immunomodulation of Skin Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10462, doi. 10.3390/ijms241310462
- By:
- Publication type:
- Article
The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 12, p. 1635, doi. 10.3390/cells12121635
- By:
- Publication type:
- Article
Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy.
- Published in:
- Molecules, 2023, v. 28, n. 12, p. 4776, doi. 10.3390/molecules28124776
- By:
- Publication type:
- Article
PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 161, doi. 10.1002/hon.3163_107
- By:
- Publication type:
- Article
PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 351, doi. 10.1002/hon.3164_253
- By:
- Publication type:
- Article
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for early‐stage classical Hodgkin Lymphoma: Updated results from an ongoing phase 2 study (SGN35‐027 Part C).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 353, doi. 10.1002/hon.3164_254
- By:
- Publication type:
- Article
Replacing procarbazine with dacarbazine in escalated BEACOPP reduces clinical toxicity with no loss of efficacy yet protects stem cells from excess somatic mutational damage.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 356, doi. 10.1002/hon.3164_256
- By:
- Publication type:
- Article
Experimental Models for Rare Melanoma Research—The Niche That Needs to Be Addressed.
- Published in:
- Bioengineering (Basel), 2023, v. 10, n. 6, p. 673, doi. 10.3390/bioengineering10060673
- By:
- Publication type:
- Article
Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.
- Published in:
- Genes, 2023, v. 14, n. 6, p. 1295, doi. 10.3390/genes14061295
- By:
- Publication type:
- Article